ATE404677T1 - Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen - Google Patents

Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen

Info

Publication number
ATE404677T1
ATE404677T1 AT01935595T AT01935595T ATE404677T1 AT E404677 T1 ATE404677 T1 AT E404677T1 AT 01935595 T AT01935595 T AT 01935595T AT 01935595 T AT01935595 T AT 01935595T AT E404677 T1 ATE404677 T1 AT E404677T1
Authority
AT
Austria
Prior art keywords
differentiative
cellular proliferative
bone associated
disease
present
Prior art date
Application number
AT01935595T
Other languages
English (en)
Inventor
David White
Kyle Macbeth
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of ATE404677T1 publication Critical patent/ATE404677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
AT01935595T 2000-05-16 2001-05-16 Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen ATE404677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57168900A 2000-05-16 2000-05-16

Publications (1)

Publication Number Publication Date
ATE404677T1 true ATE404677T1 (de) 2008-08-15

Family

ID=24284652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01935595T ATE404677T1 (de) 2000-05-16 2001-05-16 Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen

Country Status (7)

Country Link
US (1) US20020086302A1 (de)
EP (1) EP1294902B1 (de)
AT (1) ATE404677T1 (de)
AU (1) AU2001261674A1 (de)
DE (1) DE60135339D1 (de)
ES (1) ES2310554T3 (de)
WO (1) WO2001088157A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077001A1 (en) * 2002-08-02 2004-04-22 Millennium Pharmaceuticals Inc. Use for carboxypeptidase-A4 in the diagnosis and treatment of metabolic disorders
WO2008012476A2 (fr) * 2006-07-26 2008-01-31 L'oreal Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique
FR2904223B1 (fr) * 2006-07-26 2013-01-11 Oreal Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
ES2122912B1 (es) * 1996-09-20 2000-10-01 Uviversitat Autonoma De Barcel Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
WO2000078961A1 (en) * 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU743092B2 (en) * 1997-04-10 2002-01-17 Charles Gilvarg Method of detecting procarboxypeptidase A and carboxypeptidase A levels in biological fluids
CA2338386A1 (en) * 1998-08-10 2000-02-24 Incyte Pharmaceuticals, Inc. Proteases and associated proteins

Also Published As

Publication number Publication date
EP1294902A2 (de) 2003-03-26
WO2001088157A2 (en) 2001-11-22
AU2001261674A1 (en) 2001-11-26
EP1294902B1 (de) 2008-08-13
DE60135339D1 (de) 2008-09-25
WO2001088157A3 (en) 2002-05-16
US20020086302A1 (en) 2002-07-04
ES2310554T3 (es) 2009-01-16

Similar Documents

Publication Publication Date Title
WO2004065576A3 (en) Methods and compositions for the treatment of urological disorder using differential expressed polypeptides
EP1403372A3 (de) Zusammenstellung und Verfahren zur Behandlung und Diagnose von Herz-Kreislauferkrankungen
WO2000035473A3 (en) Methods for detection and use of differentially expressed genes in disease states
WO2003065006A3 (en) Methods and compositions for treating cancer
EP1562897A4 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
WO2004092405A3 (en) Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
BR0011000A (pt) Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico
EP1100547A4 (de) Zusammensetzungen und verfahren für die behandlung und diagnose von herzgefässerkrankungen.
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
DE50103907D1 (de) Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis
ATE450622T1 (de) Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit
SE0102147D0 (sv) New methods
WO2001081634A3 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
WO2004063340A3 (en) Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 4
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
WO2003070883A3 (en) Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
ATE404677T1 (de) Behandlungsverfahren unter verwendung von 17906 und dessen anwendungen
ATE530667T1 (de) Kcnn3 als diagnostisches und therapeutisches target für alzheimer-krankheit
WO2003073983A3 (en) Methods and compositions in treating pain using diacylglycerol kinase epsilon
ATE495269T1 (de) Adarb2 proteine als diagnostische und therapeutische targets für neurodegenerative erkrankungen
WO2003050504A3 (en) Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
WO2003061573A3 (en) Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
WO2004080535A3 (en) Methods and compositions for treating aids and hiv-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982, or 46777
WO2003053364A3 (en) Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties